U.S. Physical Therapy Files 8-K

Ticker: USPH · Form: 8-K · Filed: May 2, 2024 · CIK: 885978

Sentiment: neutral

Topics: 8-K, other-events

Related Tickers: USPHY

TL;DR

USPHY filed an 8-K, but details are scarce.

AI Summary

U.S. Physical Therapy, Inc. filed an 8-K on May 2, 2024, to report other events. The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.

Why It Matters

This filing indicates that U.S. Physical Therapy, Inc. has reported an event requiring immediate disclosure to the SEC, but the specific nature of the event is not detailed in the provided text.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and lacks specific financial or operational details that would typically indicate higher risk.

Key Players & Entities

FAQ

What specific event is U.S. Physical Therapy, Inc. reporting in this 8-K filing?

The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.

When was this 8-K filing submitted to the SEC?

The filing was submitted on May 2, 2024.

What is the principal executive office address for U.S. Physical Therapy, Inc.?

The principal executive offices are located at 1300 West Sam Houston Parkway, Suite 300, Houston, Texas 77043.

What is the IRS Employer Identification Number for U.S. Physical Therapy, Inc.?

The IRS Employer Identification Number is 76-0364866.

Under which section of the Securities Exchange Act is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 603 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-05-02 16:06:25

Filing Documents

01 Other Event

ITEM 8.01 Other Event. Regg Swanson has been nominated for re-election as a director at the Company's Annual Meeting of Shareholders to be held on May 21, 2024. Mr. Swanson has been a director since 2007, and was employed by Star PT, Limited Partnership (the "Subsidiary"), a Company subsidiary, from 2007 through January 31, 2020. During the period from 2019 through the current period, Mr. Swanson did not serve as an officer of either the Company or the Subsidiary, has not been in charge of any business unit, division or policy function for either the Company or the Subsidiary, and he has had no day-to-day responsibilities. Mr. Swanson's role with the Subsidiary during his time of employment during 2019 and 2020 involved customer relations. As a result, Mr. Swanson has been independent from the Company from the period 2019 through the current period. The Company lists Mr. Swanson as an independent director in its Proxy Statement dated as of April 15, 2024. The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. U.S. PHYSICAL THERAPY, INC. Dated: May 2, 2024 By: /s/ CAREY HENDRICKSON Carey Hendrickson Chief Financial Officer (duly authorized officer and principal financial and accounting officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing